Cargando…

Identification of a mesenchymal-related signature associated with clinical prognosis in glioma

Malignant glioma with a mesenchymal (MES) signature is characterized by shorter survival time due to aggressive dissemination and resistance to chemoradiotherapy. Here, this study used the TCGA database as the training set and the CGGA database as the testing set. Consensus clustering was performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhengwei, Chen, Jie, Huo, Xiuhao, Zong, Gang, Huang, Kebing, Cheng, Meng, Sun, Libo, Yue, Xiaoyu, Bian, Erbao, Zhao, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148476/ https://www.ncbi.nlm.nih.gov/pubmed/33875619 http://dx.doi.org/10.18632/aging.202886

Ejemplares similares

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma
por: Huang, Kebing, et al.
Publicado: (2021)

Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma
por: Li, Lianxin, et al.
Publicado: (2022)

Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc
por: Bian, Erbao, et al.
Publicado: (2021)

A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma
por: Yang, Zhihao, et al.
Publicado: (2022)

A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
por: Zheng, Yinfei, et al.
Publicado: (2022)

Ubiquitination Destabilizes Protein Sphingosine Kinase 2 to Regulate Glioma Malignancy
por: Wang, Hongliang, et al.
Publicado: (2021)

Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression
por: Yang, Zhihao, et al.
Publicado: (2023)

Downregulation of ubiquitin-associated protein 2-like with a short hairpin RNA inhibits human glioma cell growth in vitro
por: ZHAO, BING, et al.
Publicado: (2015)

A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma
por: Bian, Erbao, et al.
Publicado: (2019)

Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma
por: Zong, Wei-Feng, et al.
Publicado: (2022)

Identification of a novel MYC target gene set signature for predicting the prognosis of osteosarcoma patients
por: Gong, Deliang, et al.
Publicado: (2023)

A novel cuproptosis-related gene signature to predict prognosis in Glioma
por: Zhang, Mengyang, et al.
Publicado: (2023)

Identification and Validation of Prognostically Relevant Gene Signature in Melanoma
por: Gao, Yali, et al.
Publicado: (2020)

Identification of a gene signature associated with radiotherapy and prognosis in gliomas
por: Li, Shu, et al.
Publicado: (2017)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Predicting the prognosis of glioma by pyroptosis‐related signature
por: Chao, Bo, et al.
Publicado: (2021)

Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma
por: Zhou, Zhengui, et al.
Publicado: (2018)

Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas
por: Huang, Ruoyu, et al.
Publicado: (2020)

Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma
por: Wang, Peng, et al.
Publicado: (2020)

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
por: Su, Jun, et al.
Publicado: (2019)

Computational analysis of the mesenchymal signature landscape in gliomas
por: Celiku, Orieta, et al.
Publicado: (2017)

Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma
por: Liu, Zhizheng, et al.
Publicado: (2021)

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma
por: Wang, Weichen, et al.
Publicado: (2022)

Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
por: Chen, Zhigang, et al.
Publicado: (2023)

Meg3 Induces EMT and Invasion of Glioma Cells via Autophagy
por: Yang, Zhihao, et al.
Publicado: (2020)

Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients
por: Zhang, Yize, et al.
Publicado: (2021)

Identification of a Novel Gene Signature Based on Kinesin Family Members to Predict Prognosis in Glioma
por: Pan, Dongxiao, et al.
Publicado: (2023)

Identification of a copper metabolism‐related gene signature for predicting prognosis and immune response in glioma
por: Li, Ling, et al.
Publicado: (2023)

Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
por: Brown, Christine E., et al.
Publicado: (2013)

Identification of the Prognostic Signatures of Glioma With Different PTEN Status
por: Zhang, Pei, et al.
Publicado: (2021)

A Bioinformatics-Based Analysis of an Anoikis-Related Gene Signature Predicts the Prognosis of Patients with Low-Grade Gliomas
por: Zhao, Songyun, et al.
Publicado: (2022)

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma
por: Liu, Zaoqu, et al.
Publicado: (2021)

EGR1 modulated LncRNA HNF1A-AS1 drives glioblastoma progression via miR-22-3p/ENO1 axis
por: Ma, Chunchun, et al.
Publicado: (2021)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma
por: Tao, Chuming, et al.
Publicado: (2021)

Correction: Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
Publicado: (2018)

Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma
por: Qi, Ying, et al.
Publicado: (2022)

Identification of an energy metabolism-related six-gene signature for distinguishing and forecasting the prognosis of low-grade gliomas
por: Liu, Guoli, et al.
Publicado: (2023)

Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma
por: Shi, Junfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ej2bbpabrpopvpdacvq1oi719